Vol.

184,

No.

April

30,

1992

BIOCHEMICAL

2, 1992

AND

BIOPHYSICAL

RESEARCH

COMMUNICATIONS Pages

ADDITIVE

ENHANCEMENT OF NEUTROPHIL COLLAGENASE BY HOC1 AND CATHEPSIN G

560-567

ACTIVITY

W. Winn Chatham, Warren D. Blackburn, Jr., and Louis W. Heck Division of Clinical Immunology and Rheumatology Department of Medicine, The University of Alabama at Birmingham and Department of Veteran’s Affairs, Birmingham, Alabama Received

March

9,

1992

Summary: Using preparations of latent collagenase derived from neutrophil specific granule extracts, the relative effects of cathepsin G and HOC1 on activation of neutrophil collagenase were determined using a quantitative collagenase assay. Enhancement of collagenase activity by cathepsin G and physiologically relevant concentrations of HOC1 were comparable, but HOC1 mediated collagenase activation was reversible in the presence of HOC1 scavenger. Collagenase activity in preparations treated with cathepsin G and HOC1 simultaneously or sequentially was significantly greater than activity in preparations treated with HOC1 or cathepsin G alone. The results indicated additive, yet independant enhancing effects of HOC1 and cathepsin G on activity of neutrophil collagenase. c 1992Academic Press,1°C.

Human

neutrophil

collagenase is a metalloprotease

specific granules of neutrophils released extracellularly

(1). Depending

may be predominantly

activated (2). Ligands that induce significant

stored in latent form within

upon the PMN

activating ligand, HNC

latent or a significant generation

portion

may be

of activated HNC also induce

significant generation of HOC1 and several studies indicate that latent HNC can be activated by this compound including

(3,4,5).

Serine proteases with trypsin or chymotrypsin-like

the PMN azurophilic

granule constituent

activity,

cathepsin G, are also capable of

activating HNC (4). Results from at least one study suggest that cathepsin G contributes to HNC activation during PMN stimulation with phorbol esters (6); however, the respective roles of HOC1 and cathepsin G in facilitating

HNC activation during PMN stimulation by

physiologic ligands in vivo remains uncertain. Abbreviations collagenase; Sue-AAPPpNa,

used: PMN, polymorphonuclear leukocyte; HNC, human neutrophil SAIgG, surface associated IgG; DFP, diisopropyl fluorophosphate; succinyl-(alanyl)2-prolyl-phenylalanine-p-nitroanilide.

Vol.

184,

No.

2,

Incubation

1992

BIOCHEMICAL

AND

WOPHYSICAL

RESEARCH

COMMUNICATIONS

of neutrophils with SAIgG , a model for PMN interactions with immune

complexes, results in release of activated HNC in association with significant generation of HOC1 and extracellular release of cathepsin G (1,5,7). Although these observations suggest that both HOC1 and cathepsin G potentially

contribute to activation of HNC in vivo, the

relative effects of these PMN products on HNC activation have not been determined using quantitative

measures of collagenase activity. Using a quantitative

preparations

of latent HNC that are free of cathepsin G activity, we determined

of HOC1 and cathepsin G, alone or in combination,

MATERIALS

collagenase assay and the effects

on HNC activation.

AND METHODS

Reapents and Materials. CM cellulose and DE cellulose were obtained from Pharmacia (Piscataway, N.J.). Percoll, DFP , L-methionine, mersalyl, and other chemical reagents were obtained from Sigma (St. Louis, MO). Sue-AAPPpNa was obtained from Cal Biochem (La Jolla, Ca.). Clostridial collagenase was obtained from Worthington Biochemical (Freehold, N.J.). Preparation of latent HNC from neutroDhi1 soecific granules. Neutrophils were prepared from blood of normal donors using established methods (1). For each preparation, 3 x lo8 PMN were suspended in buffer containing 15 mM CaCl,, 100 mM KCl, 3 mM NaCl, 3.5 mM MgCl, and 10 mM Pipes, pH 7.4, and sonicated in the presence of 1.0 mM NaN,, 5 mM Lmethionine, and 1.0 mM DFP. Specific granules in the cell lysate were then isolated on Percoll gradients as previously described (8). Following separation from the Percoll by ultracentrifugation (35,000 g x 2 hr), the granules were suspended in 3.0 ml of HBSS with 1.0 mM DFP, to which 0.1% Triton X-100 was added. The granule contents (average protein content = 600 pg/ml) were dialyzed against 50 mM sodium acetate, pH 6.0 with 15 mM CaCl,, then applied over a 1.5 x 3 cm column of CM cellulose equilibrated with the same buffer. The exclusion fraction from the column was collected and dialyzed against 10 mM Tris with 1 mM CaCl,, pH 8.0, then applied over a 1.5 by 3 cm DE cellulose column equilibrated in the same buffer. Following three column washes, collagenase adherant to the column was eluted with 50 mM NaCl in 10 mM Tris/l mM CaCl, and the eluted mixture (mean protein concentration = 12 pg/ml) was dialyzed into HBSS. Specific collagenase activity in mersalyl (1 mM) treated aliquots of the final HNC preparation averaged 0.024 units’/pg (a 140-fold enhancement relative to the specific granule extract) and was consistently three to four times higher than that in aliquots not treated with mersalyl. No cathepsin G activity could be detected in the final HNC preparation during a 24 hour incubation with Sue-AAPPpNa . Preuaration of Catheosin G. Neutrophil cathepsin G was purified from human neutrophils as previously prescribed (9). The cathepsin G preparation had no evidence of collagenase activity and 1.0 ug released 83.4 pmole/min of p-nitrophenol from Sue-AAPPpNa (37°C). Activation of latent HNC by HOC1 and/or CatheDsin G. The final latent HNC preparation was diluted with HBSS sufficient to yield a collagenase activity of approximateIy 20 ng/min when 1.0 mM mersalyl was added to an aliquot of the preparation. Aliquots (l.O2.0 ml) of the latent HNC preparation were then incubated for one hour at 37°C with either HOCl, cathepsin G or HOC1 in combination with cathepsin G followed by addition of 1.0 mM DFP and determination of collagenase activity. Aliquots of the latent HNC preparation lone unit of collagenase cleaves 1.0 pg of collagen/minute. 561

Vol.

184,

No.

2,

1992

BIOCHEMICAL

AND

BIOPHYSICAL

RESEARCH

COMMUNICATIONS

were also treated sequentially with cathepsin G for one or two hours (terminated by addition of DFP), followed by addition of varied concentrations of HOC1 or mersalyl. Lmethionine (10 mM) was added to some of the treated aliquots prior to determination of collagenase activity. Collagenase assays. Triplicate 200 ul aliquots of treated or untreated HNC preparations were incubated for 18 hours (37°C) with reconstituted [3H]-labeled type I collagen fibrils in the presence of 1.0 mM DFP (10). Collagenase activity in each aliquot was calculated from radioactivity released into the aliquot and radioactivity released following incubation of comparable fibrils with 250 ug/ml clostridial collagenase (2).

RESULTS Activation

of latent HNC bv HOCl. To determine

optimal HOC1 concentrations

required for activation of latent HNC, aliquots of each specific granule derived preparation containing predominantly

latent HNC were treated for one hour with O-1 mM HOC1 (Figure

1). Significant increases in collagenase activity were noted in aliquots treated with lo-100 PM (final concentration)

HOCl.

Comparable results were obtained when HOC1 was added

in the presence of DFP (data not shown). Radioactivity release by collagen fibrils incubated with HBSS containing only lo-100 PM HOC1 or by HOC1 treated HNC preparations

to

which 2 mM EDTA was added did not exceed that noted for fibrils incubated with HBSS alone (data not shown). Activation of latent HNC bv catheDsin G. Depending on the amount of cathepsin G used and incubation time, incubation of latent HNC preparation with cathepsin G alone resulted in enhancement

of collagenase activity comparable to that noted for preparations incubated

CONCENTRATION

HOCL

(FM)

Figure 1. Effects of HOC1 on collagenase activity in specific granule derived latent HNC preparations. One ml aliquots of three different latent HNC preparations were treated for one hour (37°C) with concentrations of HOC1 shown on the abscissa. Collagenase activity was then determined in HOC1 treated and untreated preparations as described in the methods. Values depicted on graph represent mean (+ SEM) percent increase in collagenase activity of HNC preparations treated with indicated doses of HOC1 relative to activity in control (untreated) preparations. 562

Vol.

184,

No.

BIOCHEMICAL

2, 1992

AND

BIOPHYSICAL

RESEARCH

COMMUNICATIONS

Table 1. Activation of latent HNC by Cathepsin G Treatment

Collagenase Activity (ng/rnin)

none 1.0 pg CG

10.5 + 1.36

100 2 13.6

13.3 5 .83

127 zt 8.4

2.5 ,ug CG

15.5 5 1.40

148 + 13.2

5.0 pg CG 10.0 pg CG

17.1 t .25

163 k 26.0

21.0 + 1.70

200 + 19.4

3.1 2 .28

29 !I 2.9

10.0 pg CG + EDTA*

Percent of Control

One ml aliquots of a specific granule derived latent HNC preparation were treated one hour (37°C) with O-10 pg puified cathepsin G, followed by addition of 1 mM DFP. Collagenase activities in the treated and untreated preparations were then determined as described in the methods section. Values in table denote mean (n =3) + SD collagenase activity in treated or untreated aliquots. “EDTA (1.0 mM) added prior to determination of coIlagenase activity.

with HOC1 alone (Table 1). Incubation

of HNC with cathepsin G beyond two hours did not

result in further increases in collagenase activity and incubation beyond eight hours resulted in loss of activity (data not shown). Effects of HOC1 scavenger on activated HNC. latent HNC by exogenous hypochlorite collagenase activity was determined

To determine whether activation

of

persisted in the presence of HOC1 scavenger,

in aliquots of HNC preparation

to which 10 mM L

methionine was added following one hour treatment of the preparation with 100 uM HOCl. Addition

of L-methionine

resulted in significant, but not complete attenuation

mediated HNC activation (Figure 2). L-methionine HNC preparations

of HOCI-

had no effect on collagenase activity in

treated with cathepsin G (Figure 2) or mersalyl (data not shown).

Combined affects of HOC1 and cathepsin G on HNC activation.

Treatment

of the

latent HNC preparation with HOC1 and cathepsin G simultaneously resulted in significantly greater collagenase activity relative to preparations treated with HOC1 or cathepsin G alone (Figure 3). Comparable

but slightly higher incremental

increases in collagenase activity

were observed when latent HNC preparations were treated sequentially with cathepsin G for one hour (terminated

with DFP) then 50 I.LM HOCl. Addition

of L-methionine

following

treatment of HNC preparations with HOC1 and cathepsin G resulted in collagenase activity comparable to preparations in HNC preparations

treated with cathepsin G alone (Figure 3). Collagenase activity

treated concurrently

with HOC1 and cathepsin G in the presence of 563

Vol.

184, No. 2, 1992

BIOCHEMICAL

AND BIOPHYSICAL

ncontrol

RESEARCH COMMUNICATIONS 0 Control E;gt,epsin

fS8 Cathepsin

G *

G

ET!3Cothepmn G + HOC1 ~Cothepsm G -DFP+HOCI CHI Cathepsin C +HOCL-Methi

Methionine

Figure 2. Effects of an HOC1 scavenger on HNC activity. Aliquots (2.0 ml) of latent HNC preparation were incubated for one hour (37°C) in the presence or absence of either 100 PM HOC1 or 10 bg/ml cathepsin G. Following incubation, 1 mM DFP was added to each aliquot, followed by addition of Lmethionine (10 mM final concentration) to half of each aliquot. Bar heights denote mean (n=3)+SD collagenase activities determined for each treated and untreated sample, determined as described in the methods section. Comparable results were obtained in identical experiments using two other latent HNC preparations. Figure 3. Combined Effects of HOC1 and Cathepsin G on HNC Activity. Aliquots (2.0 ml) of each latent HNC preparation were incubated one hour (37°C) in the presence or absence of either 100 yM HOCI, 10 pg/‘ml cathepsin G, or 100 PM HOC1 and 10 pg/ml cathepsin G simultaneously. An additional aliquot of each preparation was incubated one hour with 10 fig/ml of cathepsin G followed by addition of 1 mM DFP and 100 PM HOCl. Prior to determination of collagenase activity (described in methods), 10 mM L-methionine was added to half of the aliquot treated with HOC1 and cathepsin G concurrently. Bar heigths denote mean (n=3)tSEM percent increases in collagenase activity for treated aliquots relative to activity in corresponding control (untreated) preparations.

1.0 mM DFP was comparable to that noted for preparations

treated with HOC1 alone (data

not shown). Regardless of the dose of oxidant or organomercurial or mersalyl to aliquots of latent HNC pretreated

used, addition of HOC1

two hours with cathepsin G resulted in

collagenase activity exceeding that in the cathepsin G treated preparation latent HNC aliquots treated only with the corresponding concentration

as well as that in

of HOC1 or mersalyl

(Figure 4).

DISCUSSION Since imunoglobulin

latent

HNC

secreted

into

phagolysosomes

surrounding

tissue bound

may interact with both HOC1 and cathepsin G, the relative effects of these

PMN products on HNC activation confirm that HOC1 concentrations

are of significant interest. The results presented here comparable to those generated during PMN stimulation 564

Vol.

184,

No.

2,

BIOCHEMICAL

1992

AND

BIOPHYSICAL

RESEARCH

COMMUNICATIONS

A-ACGtMedyl *- - -* hkrsoiyi olane

O-OCGWHOCL .-0 HOCL olone 404

6

0 A0

10

100

0

0

1

.l Mersolyl

HOC1 (/Ad)

2.5

(mM)

Figure 4. Enhancing effects of HOC1 (4A) or Organomercurial (4B) on HNC Preparations Treated or Untreated with Cathepsin G. Latent HNC preparation was incubated for two hours (37°C) in the presence or absence of 10 pg/ml cathepsin G. Following addition of 1 mM DFP, O-100 PM HOC1 or O-5 mM mersalyl (final concentrations) were added to 1.0 ml aliquots of both cathepsin G treated and untreated preparations prior to determination of collagenase activity. Values depicted on graphs represent mean (“SD) of triplicate determinations of collagenase activity for each sample. * p < .05 CG*SObM HOC1 vs 50 PM HOC1 alone.

with SAIgG (50pM)

(5) are capable of enhancing collagenase activity in preparations

of

latent HNC. These results also confirm that HOC1 can activate HNC in the absence of cathepsin G (4), as there was no detectable preparation,

cathepsin G activity in the final HNC

and addition of DFP to the latent HNC preparation did not alter the enhancing

affects of HOC1 on collagenase activity. Although initial cleavage of HNC by cathepsin G during cell lysis and preparation unlikely

as cell sonication

performed

of the specific granule extracts may have occurred, this is

and treatment

of the granules with Triton

were

in the presence of DFP.

The observed loss of collagenase activity following preparations

detergent

of HOCI-activated

addition of HOC1 scavenger to

HNC suggests a potential mechanism of regulating HNC

activity in vivo, in that loss of enzymatic activity may occur during diffusion activated HNC

away from the phagolysosome

scavenged. This observation organomercurial organomercurials,

mediated

into a milieu

where HOC1 is readily

is analagous to findings in a previous activation

HOC1 is thought

report

of HNC was shown to be reversible to mediate activation

cysteine sulfhydryl moeity contained within a PRCGVPD metal ion (12,13). The failure of methionine

of HOC1

in which (11). Like

of HNC by dissociating

the

sequence from the active site zinc

concentrations

one hundred-fold

in excess of

HOC1 to completely reverse HOC1 mediated enhancement of collagenase activity could be 565

Vol.

184,

No.

2,

1992

BIOCHEMICAL

due to greater affinity organomercurial

AND

BIOPHYSICAL

RESEARCH

COMMUNICATIONS

of the oxidant for the cysteine sulhydryl group.

activated zinc-metalloproteases

Alternatively,

have been shown to undergo autocatalytic

cleavage with retention of enzyme activity (14), and a similiar occurance for HOC1 activated HNC may account for a portion of the enzyme preparation

remaining active in the presence

of HOC1 scavenger. Although treatment of latent HNC with cathepsin G alone resulted in augmentation collagenase activity comparable

to that noted for HOC1 treated preparations,

of

the even

greater increase in collagenase activity noted following treatment with HOC1 and cathepsin G concurrently

suggests the effects of HOC1 and cathepsin G on HNC activity may be

additive. Augmented proteolytic activation of HNC by cathepsin G in the presence of HOC1 could account for these observations, but comparable were noted in preparations Furthermore,

if not higher collagenase activities

treated sequentially with cathepsin G, DFP, and then HOCl.

addition of HOC1 scavenger to preparations

HOC1 and cathepsin G simultaneously noted for preparations activity independent

which had been treated with

resulted in collagenase activity comparable to that

treated with cathepsin G alone, suggesting HOC1 effects on enzyme of those mediated by cathepsin G.

Higher collagenase activity observed in mixtures treated with HOC1 and cathepsin G in combination

could also be accounted for by activation

enzyme relative

to preparations

of a greater percentage of latent

treated with either agent alone.

However,

maximizing cathepsin G mediated HNC activation by two hour incubation with cathepsin demonstrated

G, the subsequent

addition

despite

of latent HNC

of HOC1 or mersalyl in concentrations

to optimize HNC activity resulted in collagenase activity which exceeded that

in the cathepsin G treated preparation the optimal concentrations

as well as latent HNC preparations

treated only with

of HOC1 or mersalyl. These results, suggesting independant

effects of cathepsin G and HOC1 on HNC activity that are additive, may prove to be an important consideration in developing interventions to abrogate tissue injury by neutrophils. Future studies correlating

molecular characteristics of HNC treated with HOC1 and/or

cathepsin G with characteristics of HNC generated in inflamed tissues may further clarify which of these potential mechanisms of regulating HNC activity are operative in vivo.

REFERENCES 1.

2. 3.

Murphy, G., Reynolds, J.J. Bretz, U., and Baggiolinz, M. (1977) Biochem J. 162,195 197. Chatham, W. W., Heck, L.W., and Blackburn, W.D., Jr. (1990) Arthritis and Rheumatism 33, 228-234. Weiss, S.J., Peppin, G., Ortiz, X., Ragsdale, C. and Test, S.T. (1985) Science 227, 747-749. 566

Vol.

4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14.

184,

No.

2,

1992

BIOCHEMICAL

AND

BIOPHYSICAL

RESEARCH

COMMUNICATIONS

Saari, H., Suomalainen, K., Lindy, O., Kontinnen, Y., and Sorsa, T. (1990) Biochem. Biophys. Res. Comm. 171, 979-987. Chatham, W.W., Heck, L.W., and Blackburn, W.D., Jr. (1992) Matrix (supplement), In press. Capodici, C., Muthukumaran, G., Amorusu, M., and Berg, R.A. (1989) Inflammation 13, 245-258. Henson, P.M. and Johnston, R.B. (1987) J. Clin. Invest. 79, 669-674. Borregard, N., Heiple, J.M., Simons, E.R., and Clark, R.A. (1983) J. Cell Biol., 97, 52-61. Heck, L.W., Rostand, K.S., Hunter, F.A., and Bhown, A. (1986) Anal. Biochem., 158, 217-227. Johnson-Win& B. (1990) Anal. Biochem. 104, 175-181. Mookhtiar, K.A. and VanWart, H.E. (1990) Biochemistry 29, 10620-10627. Springman, E.B., Angleton, E.L., Birkedal-Hansen, H., and VanWart, H.E. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 364-368. Hasty, K.A., Pourmotabbed, T.F., Goldberg, E.I., Thompson, J.P., Spinella, D.G., Stevens, R.M. and Mainardi, C.L. (1990) J. Biol. Chem. 265, 11421-11424. Grant, G., Eisen, A.Z., Marmar, B.L., Roswit, W.T. and Goldberg, G.I. (1987) J. Biol. Chem. 262, 5886-5889.

567

Additive enhancement of neutrophil collagenase activity by HOCl and cathepsin G.

Using preparations of latent collagenase derived from neutrophil specific granule extracts, the relative effects of cathepsin G and HOCl on activation...
550KB Sizes 0 Downloads 0 Views